Vaccine Viewpoints in association with the World Vaccine Congress Europe 2014

Vaccine Viewpoints: in association with the World Vaccine Congress Europe 2014

 Hear from the leaders of the vaccine industry on current issues and future progression. Today’s leaders of the vaccine industry have come together to discuss the latest developments and challenges within their field. Gain a preview into the key areas of interest that circulate the world of vaccine developments, expressed in Vaccine Viewpoints, in association with the World Vaccine Congress …

Top 4 Challenges for Vaccine Manufacturers

Recently we undertook the research for the 15th annual World Vaccine Congress, and so asked what the biggest challenges are for each segment of the market. When we spoke to vaccine manufacturers, these came up as the 4 biggest issues:   1)      Adjuvants Adjuvants are often lauded as the way forward to make vaccines more effective, but given how new …

Partnerships in the Emerging Markets

Emerging markets play a key role in the growth of any industry. At the World Vaccine Congress in April 2012, Allan Jarvis, Vice President, Corporate Development, sanofi Pasteur emphasized the importance of successful partnering in emerging markets for the future of the Vaccines industry. His presentation centred on a portfolio of products relevant to the Developed and Emerging Markets. Through …

A retrospective look at FierceBiotech’s Top 15 biotechs for 2011

Last September, we posted this blog on The Fierce 15, more specifically, on the 3 biotechs that focused on vaccines.  Looking retrospectively, do you think these 3 will remain a part of the Top 15? What changes do you think will occur?  How far forward have these companies developed in the past year? Take a look below at what was …

Investing in #vaccine biotechs? See 25 selected companies in one go

The industry's largest vaccine research and business development congress, 12th World Vaccine Congress Washington, taking place from 10-13 April at the Gaylord Convention Center, Maryland, USA is offering you first mover advantage when assessing the sectors' most promising research and technology biotech's. On 10th April 2012, 25 of the vaccine industry's most promising Biotech's will be pitching their pre-clinical, phase …